FactSet to Participate in the Barclays Americas Select Franchise Conference

NORWALK, Conn., May 02, 2022 (GLOBE NEWSWIRE) — FactSet (NYSE:FDS | NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, today announced that Linda Huber, Chief Financial Officer of FactSet, will participate in a virtual fireside chat at 5:00 a.m. EDT / 10:00 a.m. BST at the Barclays Americas Select Franchise […]

Constellation Brands Prices Offering of Senior Notes

VICTOR, N.Y., May 02, 2022 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that it priced the public offering (the “offering”) of $1.85 billion aggregate principal amount of Senior Notes, consisting of (i) $550.0 million of 3.60% Senior Notes due 2024 (the “2024 notes”) for a public offering […]

International CCS Knowledge Centre appoints James Millar President and CEO

Regina, SK, May 02, 2022 (GLOBE NEWSWIRE) — The International CCS Knowledge Centre has appointed James Millar to the position of President and Chief Executive Officer, effective May 24. A highly respected executive with deep experience in energy, industrial infrastructure, and public policy, Millar arrives at a critical inflection point in the development of carbon […]

Converge Technology Solutions Corp. Completes Acquisition of Interdynamix Systems

TORONTO and GATINEAU, Québec, May 02, 2022 (GLOBE NEWSWIRE) — Converge Technology Solutions Corp. (“Converge” or “the Company”) (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF) a software-enabled IT & Cloud Solutions provider, is pleased to announce the closing of its previously signed acquisition of IDX Systems Corp. (“Interdynamix”). Converge announced the signing of the acquisition of Interdynamix on March […]

Junshi Biosciences and Coherus Receive Complete Response Letter from U.S. FDA for Toripalimab BLA

– The CRL requests a quality process change Junshi Biosciences and Coherus believe is readily addressable – – BLA resubmission anticipated by mid-summer 2022 with expected six month FDA review timeline – – Onsite inspections in China, impeded to date by COVID-19-related travel restrictions, are required for FDA’s completion of BLA review – – Toripalimab will be the first and […]

Fortuna announces the release of its fourth annual sustainability report

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) is pleased to announce that it has published its fourth annual sustainability report which summarizes the Company’s sustainability and ESG performance in 2021, and which has been prepared in accordance with GRI1 and SASB2 standards. The sustainability report […]